METOPROLOL TARTRATE tablet, film coated USA - engelsk - NLM (National Library of Medicine)

metoprolol tartrate tablet, film coated

aidarex pharmaceuticals llc - metoprolol tartrate (unii: w5s57y3a5l) (metoprolol - unii:geb06nhm23) - metoprolol tartrate 100 mg - metoprolol tartrate tablets, usp are indicated for the treatment of hypertension. they may be used alone or in combination with other antihypertensive agents. metoprolol tartrate tablets, usp are indicated in the long-term treatment of angina pectoris. metoprolol tartrate tablets, usp are indicated in the treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality. treatment with intravenous metoprolol tartrate can be initiated as soon as the patient’s clinical condition allows (see dosage and administration , contraindications , and warnings ). metoprolol tartrate is contraindicated in sinus bradycardia, heart block greater than first degree, cardiogenic shock, and overt cardiac failure (see warnings ). hypersensitivity to metoprolol and related derivatives, or to any of the excipients; hypersensitivity to other beta blockers (cross sensitivity between beta blockers can occur). sick-sinus syndrome. severe peripheral arterial circulato

METOPROLOL TARTRATE tablet, film coated USA - engelsk - NLM (National Library of Medicine)

metoprolol tartrate tablet, film coated

contract pharmacy services-pa - metoprolol tartrate (unii: w5s57y3a5l) (metoprolol - unii:geb06nhm23) - metoprolol tartrate 50 mg - metoprolol tartrate tablets are indicated for the treatment of hypertension. they may be used alone or in combination with other antihypertensive agents. metoprolol tartrate is indicated in the long-term treatment of angina pectoris. metoprolol tartrate tablets are indicated in the treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality when used alone or in conjunction with intravenous metoprolol tartrate. oral metoprolol tartrate therapy can be initiated after intravenous metoprolol tartrate therapy or, alternatively, oral treatment can begin within 3 to 10 days of the acute event (see dosage and administration, contraindications, and warnings ). metoprolol tartrate is contraindicated in sinus bradycardia, heart block greater than first degree, cardiogenic shock, and overt cardiac failure (see warnings ). hypersensitivity to metoprolol tartrate and related derivatives, or to

TEVA-METOPROLOL TABLET Canada - engelsk - Health Canada

teva-metoprolol tablet

teva canada limited - metoprolol tartrate - tablet - 100mg - metoprolol tartrate 100mg - beta-adrenergic blocking agents

TEVA-METOPROLOL TABLET Canada - engelsk - Health Canada

teva-metoprolol tablet

teva canada limited - metoprolol tartrate - tablet - 100mg - metoprolol tartrate 100mg - beta-adrenergic blocking agents

PMS-METOPROLOL-L TABLET Canada - engelsk - Health Canada

pms-metoprolol-l tablet

pharmascience inc - metoprolol tartrate - tablet - 100mg - metoprolol tartrate 100mg - beta-adrenergic blocking agents

DOM-METOPROLOL-L TABLET Canada - engelsk - Health Canada

dom-metoprolol-l tablet

dominion pharmacal - metoprolol tartrate - tablet - 100mg - metoprolol tartrate 100mg - beta-adrenergic blocking agents

METOPROLOL-L TABLET Canada - engelsk - Health Canada

metoprolol-l tablet

meliapharm inc - metoprolol tartrate - tablet - 100mg - metoprolol tartrate 100mg - beta-adrenergic blocking agents

METOPROLOL-L TABLET Canada - engelsk - Health Canada

metoprolol-l tablet

sorres pharma inc - metoprolol tartrate - tablet - 100mg - metoprolol tartrate 100mg - beta-adrenergic blocking agents

NU-METOPROLOL TABLET Canada - engelsk - Health Canada

nu-metoprolol tablet

nu-pharm inc - metoprolol tartrate - tablet - 100mg - metoprolol tartrate 100mg - beta-adrenergic blocking agents

NU-METOPROLOL (TYPE L) TABLET Canada - engelsk - Health Canada

nu-metoprolol (type l) tablet

nu-pharm inc - metoprolol tartrate - tablet - 100mg - metoprolol tartrate 100mg - beta-adrenergic blocking agents